Africa Asia Middle East عربي Français free subscription IRIN Site Map RSS find PlusNews on facebook follow PlusNews on twitter
PlusNews
Global HIV/AIDS news and analysis
Advanced search
 Thursday 02 September 2010
 
Home 
Africa 
Blog 
Weekly reports 
In-Depth reports 
Country profiles 
Fact files 
Events 
Most read 
 
Print report Share |
NIGERIA: Seizure of drug shipment threatens ARV access


Photo: IRIN
Generic ARVs make HIV/AIDS treatment more affordable for developing countries
LAGOS, 13 March 2009 (PlusNews) - Dutch customs officials have seized a consignment of generic antiretroviral (ARV) drugs bound for Nigeria, raising the health risk to HIV-positive people in need of the life-prolonging medication.

Claiming that the drugs were counterfeit and violated patent rights, Dutch authorities seized the shipment at the end of February as it passed through Schipol Airport in Amsterdam en route to Nigeria, where the drugs were to be distributed by the Clinton Foundation, an implementing partner of the country's HIV/AIDS programme.

The Nigerian government insisted that the drugs were not counterfeit but rather second-line ARVs for patients who had developed resistance to first-line medicines.

Ibrahim Umoru, Chairman of the Lagos State Branch of Persons Living with HIV/AIDS in Nigeria (NEPWAN), confirmed that more and more HIV-positive Nigerians were in need of second-line treatment due to poor drug adherence and the lack of a standard ARV regimen by the country's various HIV/AIDS treatment partners.

"Increasingly, there are many positive persons who need second-line treatment, who will benefit from the seized drugs," he told IRIN/PlusNews. "The Dutch government should release them immediately and stop playing politics with people's lives."

Nigeria, like many countries in the developing world, relies on generic drugs, which are much more affordable than their brand-name equivalents, for the treatment of life-threatening diseases.

The shipment was funded by UNITAID, an international agency that purchases drugs and diagnostics for the treatment of HIV/AIDS, malaria and tuberculosis in developing countries.

In a statement on its website, UNITAID explained that the shipment did not contain counterfeit drugs but 49kg of abacavir sulfate tablets, a second-line ARV medicine manufactured by Indian pharmaceutical company Aurobindo, which has been pre-qualified by the World Health Organization.

"UNITAID is gravely concerned for the patients who are waiting for these urgently needed medicines," the statement read. "Interruption in HIV therapy is extremely dangerous and can cause resistance to the medicines. We therefore strongly urge the Dutch government to release the medicines so that they can reach patients as soon as possible."

Local and international health and human rights groups have also condemned the seizure and called on the Dutch government to immediately release the drug shipment.

In a joint statement, Oxfam International, Health Action International and Knowledge Ecology International described the seizure as "unacceptable" and urged the European Union to urgently review and modify its regulations governing generic medicines.

A 2001 declaration by the World Trade Organization stipulates that intellectual property rules should not interfere with the ability of developing countries to protect and promote public health, the statement noted.

A spokesperson for Nigeria's Ministry of Health, Niyi Ojuolape, said the Ministry was in discussions with the Clinton Foundation to determine how the seizure will affect the country's ARV drug supply chain.

lf/ks/he


Theme(s): (PLUSNEWS) Care/Treatment - PlusNews, (PLUSNEWS) HIV/AIDS (PlusNews)

[ENDS]

[This report does not necessarily reflect the views of the United Nations]
Print report Share |
Countries
FREE Subscriptions
Your e-mail address:


Submit your request
Socialize
 More on Nigeria
  • 27/Aug/2010
    GLOBAL: IRIN/PlusNews Weekly Issue 500, 27 August 2010
  • 20/Aug/2010
    GLOBAL: IRIN/PlusNews Weekly Issue 499, 20 August 2010
  • 12/Aug/2010
    GLOBAL: Straight Talk with Dr Zeda Rosenberg, CEO of the International Partnership for Microbicides
  • 06/Aug/2010
    GLOBAL: IRIN/PlusNews Weekly Issue 497, 6 August 2010
  • 02/Aug/2010
    Analysis: HIV generics under threat from tighter patenting rules
     More on Care/Treatment - PlusNews
  • 02/Sep/2010
    SOUTH AFRICA: Survivor's guide for non-striking health workers
  • 25/Aug/2010
    UGANDA: Optimism as PEPFAR increases funding*
  • 24/Aug/2010
    KENYA: Government changes tack on HIV prevention, treatment for drug users
  • 24/Aug/2010
    KENYA: TB patients held in police cells for defaulting on treatment
  • 24/Aug/2010
    SOUTH AFRICA: Strike jeopardizes HIV treatment
     Most Read 
    UGANDA: New strains of HIV spreading in fishing communities*
    SOUTHERN AFRICA: More sterilizations of HIV-positive women uncovered
    KENYA: Camel clinics bring condoms to nomads
    SOUTH AFRICA: Survivor's guide for non-striking health workers
    Back | Home page

    Services:  Africa | Asia | Middle East | Film & TV | Photo | Radio | Live news map | E-mail subscription

    Copyright © IRIN 2010
    This material comes to you via IRIN, the humanitarian news and analysis service of the UN Office for the Coordination of Humanitarian Affairs. The opinions expressed do not necessarily reflect those of the United Nations or its Member States. Republication is subject to terms and conditions as set out in the IRIN copyright page.